Frontiers in Pharmacology | Pharmacogenetics and Pharmacogenomics

Mini Review

Published on 26 Apr 2023

Current understanding of genetic associations with delayed hypersensitivity reactions induced by antibiotics and anti-osteoporotic drugs

in Pharmacogenetics and Pharmacogenomics

Chih-Hsuan Wung
Chuang-Wei Wang
Kuo-Chu Lai
Chun-Bing Chen
Wei-Ti Chen
Shuen-Iu Hung
Wen-Hung Chung
Taiwan Severe Cutaneous Adverse Reaction Consortium

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1183491

5,210 views
5 citations

Review

Published on 19 Apr 2023

The landscape of exosomal non-coding RNAs in breast cancer drug resistance, focusing on underlying molecular mechanisms

in Pharmacogenetics and Pharmacogenomics

Malihe Rezaee
Fatemeh Mohammadi
Atoosa Keshavarzmotamed
Sheida Yahyazadeh
Omid Vakili
Yaser Eshaghi Milasi
Vida Veisi
Rohollah Mousavi Dehmordi
Sepideh Asadi
Seyedeh Sara Ghorbanhosseini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1152672

5,789 views
34 citations

Editorial

Published on 12 Apr 2023

Editorial: Liquid biopsy as a tool for precision oncology: New challenges to assess clinical response, Volume II

in Pharmacogenetics and Pharmacogenomics

Paola Ulivi

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1192549

931 views

Original Research

Published on 06 Apr 2023

Omics data integration facilitates target selection for new antiparasitic drugs against TriTryp infections

in Pharmacogenetics and Pharmacogenomics

Martin Rivara-Espasandín
Miranda Clara Palumbo
Ezequiel J. Sosa
Santiago Radío
Adrián G. Turjanski
José Sotelo-Silveira
Dario Fernandez Do Porto
Pablo Smircich

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1136321

2,277 views
7 citations

Review

Published on 03 Apr 2023

Non-coding and intergenic genetic variants of human arylamine N-acetyltransferase 2 (NAT2) gene are associated with differential plasma lipid and cholesterol levels and cardiometabolic disorders

in Pharmacogenetics and Pharmacogenomics

Kyung U. Hong
Kennedy M. Walls
David W. Hein

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1091976

2,562 views
5 citations

Review

Published on 31 Mar 2023

Non-coding RNAs: The recently accentuated molecules in the regulation of cell autophagy for ovarian cancer pathogenesis and therapeutic response

in Pharmacogenetics and Pharmacogenomics

Bi Peng
Jing Li
Yuanliang Yan
Yuanhong Liu
Qiuju Liang
Wei Liu
Abhimanyu Thakur
Kui Zhang
Zhijie Xu
Jian Wang

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1162045

2,690 views
9 citations

Editorial

Published on 29 Mar 2023

Editorial: Pharmacogenomics and ethnicity: Prevalence and clinical significance of pharmacogenomic biomarkers in indigenous and other populations

in Pharmacogenetics and Pharmacogenomics

George P. Patrinos
Luis Abel Quinones
Chonlaphat Sukasem

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1180487

2,593 views
5 citations

Original Research

Published on 20 Mar 2023

Pharmacogenomic profile of actionable molecular variants related to drugs commonly used in anesthesia: WES analysis reveals new mutations

in Pharmacogenetics and Pharmacogenomics

Juan Fernando Parada-Márquez
Nicolás David Maldonado-Rodriguez
Paula Triana-Fonseca
Nora Constanza Contreras-Bravo
Carlos Alberto Calderón-Ospina
Carlos M. Restrepo
Adrien Morel
Oscar Javier Ortega-Recalde
Daniel Felipe Silgado-Guzmán
Mariana Angulo-Aguado

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1047854

3,917 views
1 citation

Original Research

Published on 14 Mar 2023

Evaluation of limited-sampling strategies to calculate AUC(0–24) and the role of CYP3A5 in Chilean pediatric kidney recipients using extended-release tacrolimus

in Pharmacogenetics and Pharmacogenomics

Carla Galvez
Pía Boza
Mariluz González
Catalina Hormazabal
Marlene Encina
Manuel Azócar
Luis E. Castañeda
Angélica Rojo
María Luisa Ceballos
Paola Krall

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1044050

3,465 views

Original Research

Published on 14 Mar 2023

The cholesterol-lowering effect of statins is modified by LILRB5 intolerance genotype: Results from a recruit-by-genotype clinical trial

in Pharmacogenetics and Pharmacogenomics

Aleksi Tornio
Margherita Bigossi
Moneeza K. Siddiqui
Gwen Kennedy
Ala’a Melhem
Mehul K. Chourasia
Cyrielle Maroteau
Roberto Pola
Daniel I. Chasman
Alexander S. F. Doney

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1090010

2,674 views
1 citation

Editorial

Published on 03 Mar 2023

Editorial: Brief research reports in pharmacogenetics and pharmacogenomics: 2022

in Pharmacogenetics and Pharmacogenomics

Francesco Sessa
Tarek Magdy
Chonlaphat Sukasem
George P. Patrinos

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1172265

1,958 views
1 citation

Original Research

Published on 01 Mar 2023

From gene to dose: Long-read sequencing and *-allele tools to refine phenotype predictions of CYP2C19

in Pharmacogenetics and Pharmacogenomics

Lonneke J. Graansma
Qinglian Zhai
Loes Busscher
Roberta Menafra
Redmar R. van den Berg
Susan L. Kloet
Maaike van der Lee

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1076574

4,363 views
7 citations

Original Research

Published on 27 Feb 2023

Practice of CYP450 genotyping and phenotyping in children in a real-life setting

in Pharmacogenetics and Pharmacogenomics

Frédérique Rodieux
Youssef Daali
Victoria Rollason
Caroline F. Samer
Kuntheavy Ing Lorenzini

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1130100

2,967 views
7 citations

Brief Research Report

Published on 21 Feb 2023

The pharmacogenetics of CYP2D6 and CYP2C19 in a case series of antidepressant responses

in Pharmacogenetics and Pharmacogenomics

Ping Siu Kee
Simran D. S. Maggo
Martin A. Kennedy
Paul K. L. Chin

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1080117

8,426 views
10 citations

Original Research

Published on 02 Feb 2023

Combining non-negative matrix factorization with graph Laplacian regularization for predicting drug-miRNA associations based on multi-source information fusion

in Pharmacogenetics and Pharmacogenomics

Mei-Neng Wang
Yu Li
Li-Lan Lei
De-Wu Ding
Xue-Jun Xie

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1132012

2,031 views
2 citations

Original Research

Published on 02 Feb 2023

Impact of polymorphisms in CYP and UGT enzymes and ABC and SLCO1B1 transporters on the pharmacokinetics and safety of desvenlafaxine

in Pharmacogenetics and Pharmacogenomics

Sofía Calleja
Pablo Zubiaur
Dolores Ochoa
Gonzalo Villapalos-García
Gina Mejia-Abril
Paula Soria-Chacartegui
Marcos Navares-Gómez
Alejandro de Miguel
Manuel Román
Samuel Martín-Vílchez

Frontiers in Pharmacology

doi 10.3389/fphar.2023.1110460

3,537 views
7 citations